Resveratrol supplementation with selective laser trabeculoplasty may be an effective treatment option for glaucoma by ...

NDAQ:AVXL) Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of ...

Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received clinical trial ...

A study by Kanazawa University has linked daily green tea consumption to reduced white matter lesions in older adults without ...

The Proanthocyanidins markethas witnessed remarkable growth in recent years, driven by increasing awareness of the potential health benefits these natural compounds offer. Proanth ...

Research led by the Kanazawa University Graduate School of Medical Sciences has reported a significant connection between ...

Pheno Therapeutics Limited has received clinical trial authorisation (CTA) from the UK’s MHRA for its lead candidate, PTD802.

ANX005 First Potential Targeted Therapy for Guillain-Barré Syndrome Advancing Towards 1H 2025 BLA SubmissionANX007 First Potential ...

A neuroscientist has shared his top tip for reducing the risk of developing Alzheimer's disease, and it's something simple ...

Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and treatment limitations.

The product's appeal lies in its simplicity: a mix of natural ingredients, non-GMO, and manufactured in the USA in an FDA-approved and GMP-certified facility. The product also claims to be free of ...